Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
Theurer JA, Stecho W, Yoo J, Kwan K, Wehrli B, Harry V, Black M, Pinto N, Winquist E, Palma D, Richter S, Barrett JW, Danielle MacNeil S, Fung K, Howlett CJ, Nichols AC.
Theurer JA, et al. Among authors: yoo j.
Pathol Oncol Res. 2016 Jan;22(1):35-40. doi: 10.1007/s12253-015-9970-3. Epub 2015 Aug 14.
Pathol Oncol Res. 2016.
PMID: 26271341
Free article.
Clinical Trial.